Dolphin Medical Services Limited (BOM:526504)
India · Delayed Price · Currency is INR 7.20
-0.29 (-3.87%)
At close: Aug 17, 2026
Dolphin Medical Services Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 0.15 | 0.2 | 0.17 | 0.14 | 0.12 |
Cash & Short-Term Investments | 0.15 | 0.15 | 0.2 | 0.17 | 0.14 | 0.12 |
Cash Growth | -23.52% | -23.56% | 22.38% | 19.98% | 17.30% | -66.92% |
Receivables | - | 19.47 | 19.47 | 19.47 | 19.47 | 19.47 |
Inventory | - | 0.09 | 0.1 | 0.07 | 0.04 | 0.02 |
Other Current Assets | - | 0.05 | - | - | - | - |
Total Current Assets | - | 19.77 | 19.77 | 19.71 | 19.65 | 19.61 |
Property, Plant & Equipment | - | 34.35 | 30.71 | 31.34 | 31.8 | 32.43 |
Long-Term Investments | - | 4.1 | 4.1 | 4.1 | 4.1 | 4.1 |
Long-Term Deferred Charges | - | 37.85 | 37.85 | 37.85 | 37.85 | 37.85 |
Other Long-Term Assets | - | 0.1 | 0.14 | 0.14 | 0.14 | 0.14 |
Total Assets | - | 124.36 | 120.76 | 121.32 | 121.73 | 122.32 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Other Current Liabilities | - | 8.89 | 5.76 | 6.66 | 6.58 | 6.7 |
Total Current Liabilities | - | 8.89 | 5.76 | 6.66 | 6.58 | 6.7 |
Long-Term Debt | - | 8.66 | 8.66 | 8.03 | 7.55 | 6.84 |
Long-Term Deferred Tax Liabilities | - | 5.97 | 5.94 | 5.9 | 5.83 | 5.76 |
Other Long-Term Liabilities | - | 0.01 | - | - | - | - |
Total Liabilities | - | 23.54 | 20.36 | 20.59 | 19.96 | 19.3 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 151 | 151 | 151 | 151 | 151 |
Additional Paid-In Capital | - | - | 23.69 | 23.69 | 23.69 | 23.69 |
Retained Earnings | - | - | -77.52 | -77.18 | -76.14 | -74.89 |
Comprehensive Income & Other | - | -50.19 | 3.23 | 3.23 | 3.23 | 3.23 |
Shareholders' Equity | 100.81 | 100.81 | 100.4 | 100.73 | 101.77 | 103.02 |
Total Liabilities & Equity | - | 124.36 | 120.76 | 121.32 | 121.73 | 122.32 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 8.66 | 8.66 | 8.66 | 8.03 | 7.55 | 6.84 |
Net Cash (Debt) | -8.51 | -8.51 | -8.46 | -7.86 | -7.41 | -6.72 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.49 | -0.41 | -0.50 | -0.53 | -0.48 | -0.43 |
Filing Date Shares Outstanding | 1.62 | 20.95 | 15.1 | 15.1 | 15.1 | 15.1 |
Total Common Shares Outstanding | 1.62 | 20.95 | 15.1 | 15.1 | 15.1 | 15.1 |
Working Capital | - | 10.87 | 14.01 | 13.05 | 13.07 | 12.91 |
Book Value Per Share | 4.81 | 4.81 | 6.65 | 6.67 | 6.74 | 6.82 |
Tangible Book Value | 100.81 | 100.81 | 100.4 | 100.73 | 101.77 | 103.02 |
Tangible Book Value Per Share | 4.81 | 4.81 | 6.65 | 6.67 | 6.74 | 6.82 |
Land | - | - | 19.54 | 19.54 | 19.54 | 19.54 |
Machinery | - | - | 19.93 | 19.93 | 19.93 | 19.93 |
Construction In Progress | - | - | 3.07 | 3.07 | 3.07 | 3.07 |